MVP 0.53% 47.8¢ medical developments international limited

Ann: FDA Approves New Range of Respiratory Devices, page-4

  1. 2,547 Posts.
    lightbulb Created with Sketch. 85
    this could be a real kicker for Penthrox too.




    if MVP have smoothed out relationships with FDA for this "Respiratory Device" sector of sales (and shown that MVP play by the rules).... perhaps Penthrox will be selling in USA sooner than we think (without 3rd Phase 3 trial?).

    thoughts?

    -----------



    great to to review this classic MVP video.





    11:00 - UK need for painkillers... 2.1 doses just in UK.... $30-35.00 per dose?

    13:35 - rapid Euro roll-out possible to other countries.... via "mutual recognition" program across Euro borders

    16:00 - USA hospital "Emergency Admission" numbers.... massive potential

    15:00 new Penthrox delivery devices (no doubt referring to the "military-spec" Penthrox delivery system without the separate vial/ampule - for use in "high-stress" situations - eg Combat Zones)


    --------------------------


    USA dossier.png





    USA advisor.png


    USA

    $$$


    bsh
    Last edited by bigshareshead: 27/01/16
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
47.8¢
Change
0.003(0.53%)
Mkt cap ! $41.21M
Open High Low Value Volume
48.0¢ 51.5¢ 47.0¢ $15.68K 32.55K

Buyers (Bids)

No. Vol. Price($)
2 23325 47.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 375 1
View Market Depth
Last trade - 15.59pm 12/07/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.